Insider Trading activities of Jazz Pharmaceuticals Inc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Jazz Pharmaceuticals Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Jazz Pharmaceuticals Inc since year 2005. Table 2 shows the detailed insider transactions of Jazz Pharmaceuticals Inc since 2005. The reporting company's ticker symbol is JAZZ. The reporting company's CIK number is 1232524.
The total value of stock buying since 2005 is $10,920,190.
The total value of stock sales since 2005 is $1,474,853,681.
The total value of stock option exercises since 2005 is $40,409,340.


 1   2 
Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Jazz Pharmaceuticals Inc (JAZZ).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2017-10 0 $0 1,000 $150,000 0 $0
2017-09 0 $0 1,000 $153,520 0 $0
2017-08 0 $0 8,460 $1,214,491 0 $0
2017-07 0 $0 4,780 $763,794 0 $0
2017-06 0 $0 5,620 $847,330 0 $0
2017-05 0 $0 32,500 $5,002,660 0 $0
2017-04 0 $0 16,433 $2,530,997 11,458 $607,044
2017-03 0 $0 1,084 $144,242 3,646 $193,165
2017-01 0 $0 4,200 $533,186 0 $0
2016-12 0 $0 2,231 $227,372 0 $0
2016-11 2,000 $227,698 200 $22,438 0 $0
2016-10 0 $0 200 $23,632 0 $0
2016-09 0 $0 200 $25,234 0 $0
2016-08 608 $83,406 38,210 $5,046,293 0 $0
2016-07 580 $83,304 100 $14,243 0 $0
2016-06 557 $83,334 100 $14,963 0 $0
2016-05 0 $0 29,409 $4,408,038 0 $0
2016-04 0 $0 11,872 $1,714,673 0 $0
2016-03 0 $0 2,600 $328,016 0 $0
2016-02 0 $0 27,968 $3,435,197 0 $0
2016-01 0 $0 12,600 $1,706,170 0 $0
2015-12 0 $0 13,024 $1,894,258 0 $0
2015-11 0 $0 43,389 $6,157,369 0 $0
2015-10 0 $0 14,600 $1,941,362 0 $0
2015-09 0 $0 12,600 $2,086,669 0 $0
2015-08 0 $0 25,148 $4,531,363 0 $0
2015-07 0 $0 19,000 $3,372,600 4,000 $187,320
2015-06 0 $0 24,751 $4,378,249 9,494 $478,392
2015-05 0 $0 28,906 $5,093,309 13,907 $696,368
2015-04 0 $0 19,500 $3,415,505 0 $0
2015-03 0 $0 119,949 $21,529,315 7,010 $278,313
2015-02 0 $0 21,851 $3,651,626 6,851 $320,832
2015-01 0 $0 16,851 $2,714,612 1,851 $86,682
2014-12 0 $0 69,195 $11,559,024 1,347 $63,080
2014-11 0 $0 37,112 $6,365,532 13,333 $702,279
2014-10 0 $0 17,852 $2,742,792 667 $31,235
2014-09 0 $0 123,352 $20,822,680 6,167 $182,265
2014-08 0 $0 16,777 $2,256,292 5,600 $292,585
2014-07 0 $0 11,344 $1,783,320 4,822 $177,388
2014-06 0 $0 63,750 $9,558,022 3,000 $158,940
2014-05 0 $0 8,061 $1,059,773 667 $31,235
2014-04 0 $0 36,917 $5,042,400 3,667 $190,175
2014-03 0 $0 573,289 $89,505,584 6,000 $336,330
2014-02 0 $0 595,677 $95,723,862 24,014 $721,720
2014-01 0 $0 2,000 $263,640 0 $0
2013-12 0 $0 4,325 $517,585 1,325 $62,049
2013-11 0 $0 5,373 $536,380 2,373 $111,127
2013-10 0 $0 12,000 $1,018,219 5,000 $234,150
2013-09 0 $0 14,000 $1,224,220 5,000 $234,150
2013-08 0 $0 294,298 $23,936,221 7,500 $351,225
2013-07 0 $0 8,000 $583,700 0 $0
2013-06 0 $0 5,000 $341,650 1,452 $16,668
2013-05 0 $0 7,000 $412,620 0 $0
2013-04 0 $0 4,000 $218,080 0 $0
2013-03 0 $0 9,134,008 $532,341,172 92,698 $1,229,515
2013-02 0 $0 70,650 $4,110,678 0 $0
2013-01 0 $0 70,650 $3,994,335 0 $0
2012-12 0 $0 4,000 $202,200 0 $0
2012-11 0 $0 4,000 $204,440 0 $0
2012-10 0 $0 75,650 $4,442,977 0 $0
2012-08 0 $0 260,000 $11,915,500 0 $0
2012-03 0 $0 10,883,366 $539,379,618 0 $0
2012-01 0 $0 114,605 $4,989,328 1,710,855 $31,587,142
2011-12 0 $0 0 $0 46,536 $624,513
2011-11 3,000 $112,080 0 $0 0 $0
2011-08 0 $0 107,928 $3,890,048 1,399 $0
2011-07 0 $0 32,384 $1,310,580 0 $0
2010-12 0 $0 85,000 $1,547,235 25,000 $115,125
2010-11 0 $0 102,792 $1,568,909 86,663 $108,328
2010-09 6,000 $58,560 0 $0 0 $0
2010-08 60,000 $522,224 0 $0 0 $0
2010-05 838,323 $6,999,997 0 $0 0 $0
2010-03 0 $0 29,467 $337,657 0 $0
2009-12 0 $0 5,500 $41,173 0 $0
2009-11 9,788 $66,998 0 $0 0 $0
2009-09 150,000 $1,082,383 3,500 $32,861 0 $0
2009-08 0 $0 93 $648 0 $0
2008-07 4,982,909 $0 0 $0 0 $0
2008-04 129,796 $1,126,173 0 $0 0 $0
2008-03 3 $27 0 $0 0 $0
2007-11 28,638 $383,839 0 $0 0 $0
2007-06 5,212 $90,167 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Jazz Pharmaceuticals Inc insiders (JAZZ)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-10-02 Cozadd Bruce C (Chairman & CEO) Sale 1,000 150.00 150,000
2017-09-12 Cozadd Bruce C (Chairman & CEO) Sale 1,000 153.52 153,520
2017-08-25 Enright Patrick G (Director) Sale 351 148.40 52,088
2017-08-15 Miller Michael Patrick (EVP, US Commercial) Sale 200 144.38 28,876
2017-08-14 Treacy Paul (SVP, Technical Operations) Sale 1,304 143.35 186,932
2017-08-11 Schnee Elmar (Director) Sale 1,199 143.56 172,132
2017-08-11 Gray Peter (Director) Sale 717 143.29 102,738
2017-08-11 Mcsharry Heather Ann (Director) Sale 717 143.24 102,705
2017-08-11 Sohn Catherine A. (Director) Sale 662 143.29 94,857
2017-08-11 O'keefe Kenneth W (Director) Sale 662 143.24 94,822
2017-08-11 Winningham Rick E (Director) Sale 662 143.29 94,857
2017-08-11 Enright Patrick G (Director) Sale 662 143.25 94,828
2017-08-11 Berns Paul L (Director) Sale 662 143.25 94,828
2017-08-11 Riedel Norbert G (Director) Sale 662 143.25 94,828
2017-07-20 Hooper Suzanne Sawochka (EVP & General Counsel) Sale 4,580 160.00 732,800
2017-07-17 Miller Michael Patrick (EVP, US Commercial) Sale 200 154.97 30,994
2017-06-23 Hooper Suzanne Sawochka (EVP & General Counsel) Sale 420 160.00 67,200
2017-06-15 Miller Michael Patrick (EVP, US Commercial) Sale 200 150.65 30,130
2017-06-01 Winningham Rick E (Director) Sale 5,000 150.00 750,000
2017-05-11 Cozadd Bruce C (Chairman & CEO) Sale 30,000 153.42 4,602,660
2017-05-09 Hooper Suzanne Sawochka (EVP & General Counsel) Sale 2,500 160.00 400,000
2017-04-27 Hooper Suzanne Sawochka (EVP & General Counsel) Sale 2,500 160.00 400,000
2017-04-27 Wilson Karen J (SVP, Finance & PAO) Sale 1,275 160.00 204,000
2017-04-17 Miller Michael Patrick (SVP, US Commercial) Sale 200 152.56 30,512
2017-04-11 Cozadd Bruce C (Chairman & CEO) Sale 1,000 152.12 152,120
2017-04-10 Wilson Karen J (SVP, Finance & PAO) Sale 11,458 152.24 1,744,365
2017-04-10 Wilson Karen J (SVP, Finance & PAO) Option Ex 11,458 52.98 607,044
2017-03-15 Miller Michael Patrick (SVP, US Commercial) Sale 200 137.89 27,577
2017-03-08 Wilson Karen J (SVP, Finance & PAO) Option Ex 3,646 52.98 193,165
2017-03-06 Treacy Paul (SVP, Technical Operations) Sale 884 131.97 116,665
2017-01-18 Cox Russell J. (EVP & COO) Sale 4,000 127.50 510,000
2017-01-17 Miller Michael Patrick (SVP, US Commercial) Sale 200 115.93 23,186
2016-12-15 Miller Michael Patrick (SVP, US Commercial) Sale 200 103.09 20,618
2016-12-02 Enright Patrick G (Director) Sale 1,354 101.80 137,836
2016-11-15 Miller Michael Patrick (SVP, US Commercial) Sale 200 112.19 22,438
2016-11-14 O'keefe Kenneth W (Director) Buy 500 112.45 56,223
2016-11-11 O'keefe Kenneth W (Director) Buy 1,500 114.32 171,475
2016-10-17 Miller Michael Patrick (SVP, US Commercial) Sale 200 118.16 23,632
2016-09-19 Miller Michael Patrick (SVP, US Commercial) Sale 200 126.17 25,234
2016-08-25 Mulligan Seamus (Director) Sale 27,968 128.19 3,585,078
2016-08-16 Treacy Paul (SVP, Technical Operations) Sale 1,292 137.46 177,603
2016-08-15 Mcsharry Heather Ann (Director) Sale 685 136.45 93,468
2016-08-15 Sohn Catherine A. (Director) Sale 633 136.45 86,372
2016-08-15 Winningham Rick E (Director) Sale 633 136.45 86,372
2016-08-15 Enright Patrick G (Director) Sale 633 136.45 86,372
2016-08-15 Miller Michael Patrick (SVP, US Commercial) Sale 100 136.45 13,644
2016-08-15 Berns Paul L (Director) Sale 633 136.45 86,372
2016-08-15 Riedel Norbert G (Director) Sale 633 136.45 86,372
2016-08-12 Smith Karen L. (Global Head of R&D and CMO) Buy 608 137.18 83,406
2016-08-09 Cox Russell J. (EVP & COO) Sale 4,000 148.66 594,640
2016-08-09 Cozadd Bruce C (Chairman & CEO) Sale 1,000 150.00 150,000
2016-07-15 Miller Michael Patrick (SVP, US Commercial) Sale 100 142.43 14,243
2016-07-13 Smith Karen L. (Global Head of R&D and CMO) Buy 580 143.63 83,304
2016-06-15 Miller Michael Patrick (SVP, US Commercial) Sale 100 149.64 14,963
2016-06-13 Smith Karen L. (Global Head of R&D and CMO) Buy 557 149.61 83,334
2016-05-24 Mulligan Seamus (Director) Sale 27,968 150.13 4,198,807
2016-05-16 Mcsharry Heather Ann (Director) Sale 697 145.20 101,204
2016-05-16 Miller Michael Patrick (SVP, US Commercial) Sale 100 145.20 14,519
2016-05-16 Riedel Norbert G (Director) Sale 644 145.20 93,508
2016-04-25 Wilson Karen J (SVP, Finance & PAO) Sale 604 160.00 96,640
2016-04-15 Miller Michael Patrick (SVP, US Commercial) Sale 100 145.79 14,579
2016-04-13 Wilson Karen J (SVP, Finance & PAO) Sale 5,007 150.00 751,050
2016-04-12 Cox Russell J. (EVP & COO) Sale 4,000 136.98 547,920
2016-04-07 Wilson Karen J (SVP, Finance & PAO) Sale 2,161 140.90 304,484
2016-03-15 Miller Michael Patrick (SVP, US Commercial) Sale 100 129.17 12,916
2016-03-08 Cozadd Bruce C (Chairman & CEO) Sale 2,500 126.04 315,100
2016-02-23 Mulligan Seamus (Director) Sale 27,968 122.83 3,435,197
2016-01-15 Miller Michael Patrick (SVP, US Commercial) Sale 100 122.66 12,266
2016-01-12 Cozadd Bruce C (Chairman & CEO) Sale 2,500 123.81 309,525
2016-01-05 Enright Patrick G (Director) Sale 10,000 138.44 1,384,379
2015-12-15 Miller Michael Patrick (SVP, US Commercial) Sale 100 136.99 13,699
2015-12-08 Cozadd Bruce C (Chairman & CEO) Sale 2,500 139.72 349,300
2015-12-02 Enright Patrick G (Director) Sale 424 148.49 62,959
2015-12-01 Enright Patrick G (Director) Sale 10,000 146.83 1,468,300
2015-11-23 Mulligan Seamus (Director) Sale 10,243 147.65 1,512,419
2015-11-20 Mulligan Seamus (Director) Sale 17,725 145.70 2,582,567
2015-11-16 Miller Michael Patrick (SVP, US Commercial) Sale 100 134.03 13,403
2015-11-13 Mcgill Iain (SVP, Europe & Rest of World) Sale 2,821 135.73 382,885
2015-11-10 Enright Patrick G (Director) Sale 10,000 134.48 1,344,770
2015-11-10 Cozadd Bruce C (Chairman & CEO) Sale 2,500 128.53 321,325
2015-10-21 Hooper Suzanne Sawochka (EVP & General Counsel) Sale 2,000 125.00 250,006
2015-10-15 Miller Michael Patrick (SVP, US Commercial) Sale 100 131.86 13,186
2015-10-13 Cozadd Bruce C (Chairman and CEO) Sale 2,500 131.50 328,750
2015-10-05 Enright Patrick G (Director) Sale 10,000 134.94 1,349,420
2015-09-25 Miller Michael Patrick (SVP, US Commercial) Sale 100 145.23 14,522
2015-09-08 Cozadd Bruce C (Chairman and CEO) Sale 2,500 163.44 408,587
2015-09-01 Enright Patrick G (Director) Sale 10,000 166.36 1,663,560
2015-08-27 Enright Patrick G (Director) Sale 425 167.87 71,344
2015-08-11 Treacy Paul (SVP, Technical Operations) Sale 1,330 177.67 236,295
2015-08-11 Sohn Catherine A. (Director) Sale 654 177.77 116,258
2015-08-11 Hooper Suzanne Sawochka (EVP and General Counsel) Sale 4,000 177.82 711,280
2015-08-11 Cox Russell J. (EVP & Chief Commercial Officer) Sale 500 177.82 88,910
2015-08-11 Cozadd Bruce C (Chairman and CEO) Sale 2,500 177.82 444,550
2015-08-10 Gray Peter (Director) Sale 867 182.02 157,812
2015-08-10 Mcsharry Heather Ann (Director) Sale 867 181.15 157,052
2015-08-10 Sohn Catherine A. (Director) Sale 801 182.02 145,798
2015-08-10 Winningham Rick E (Director) Sale 801 181.67 145,518
2015-08-10 Enright Patrick G (Director) Sale 10,801 181.97 1,965,511
2015-08-10 Berns Paul L (Director) Sale 801 181.67 145,518
2015-08-10 Riedel Norbert G (Director) Sale 801 181.67 145,517
2015-07-14 Hooper Suzanne Sawochka (EVP & General Counsel) Sale 4,000 177.79 711,160
2015-07-14 Hooper Suzanne Sawochka (EVP & General Counsel) Option Ex 4,000 46.83 187,320
2015-07-14 Cozadd Bruce C (Chairman & CEO) Sale 5,000 177.79 888,950
2015-07-06 Enright Patrick G (Director) Sale 10,000 177.25 1,772,490
2015-06-09 Hooper Suzanne Sawochka (EVP & General Counsel) Sale 4,000 173.16 692,640
2015-06-09 Hooper Suzanne Sawochka (EVP & General Counsel) Option Ex 4,000 46.83 187,320
2015-06-09 Cozadd Bruce C (Chairman & CEO) Sale 5,000 173.16 865,800
2015-06-02 Wilson Karen J (SVP, Finance & PAO) Sale 257 180.00 46,260
2015-06-01 Wilson Karen J (SVP, Finance & PAO) Sale 5,494 179.62 986,859
2015-06-01 Wilson Karen J (SVP, Finance & PAO) Option Ex 5,494 52.98 291,072
2015-06-01 Enright Patrick G (Director) Sale 10,000 178.67 1,786,690
2015-05-26 Mcgill Iain (SVP, Europe and Rest of World) Sale 7,334 179.48 1,316,328
2015-05-26 Mcgill Iain (SVP, Europe and Rest of World) Option Ex 7,334 52.98 388,555
2015-05-12 Gray Peter (Director) Sale 704 174.50 122,848
2015-05-12 Hooper Suzanne Sawochka (EVP & General Counsel) Sale 4,000 173.85 695,400
2015-05-12 Hooper Suzanne Sawochka (EVP & General Counsel) Option Ex 2,073 46.83 97,078
2015-05-12 O'keefe Kenneth W (Director) Sale 1,218 174.90 213,025
2015-05-12 O'keefe Kenneth W (Director) Option Ex 4,500 46.83 210,735
2015-05-12 Cozadd Bruce C (Chairman & CEO) Sale 5,000 173.85 869,250
2015-05-12 Riedel Norbert G (Director) Sale 650 174.47 113,408
2015-05-11 Enright Patrick G Sale 10,000 176.31 1,763,050
2015-04-14 Hooper Suzanne Sawochka (EVP & General Counsel) Sale 4,000 181.45 725,800
2015-04-14 Cox Russell J. (EVP & COO) Sale 500 181.45 90,725
2015-04-14 Cozadd Bruce C (Chairman & CEO) Sale 5,000 181.45 907,250
2015-04-06 Enright Patrick G Sale 10,000 169.17 1,691,730
2015-03-25 Mulligan Seamus (Director) Sale 50,000 176.22 8,810,750
2015-03-18 Mulligan Seamus (Director) Sale 50,000 185.00 9,250,000
2015-03-10 Hooper Suzanne Sawochka (EVP & General Counsel) Sale 1,851 170.36 315,336
2015-03-10 Hooper Suzanne Sawochka (EVP & General Counsel) Option Ex 1,851 46.83 86,682
2015-03-10 Cozadd Bruce C (Chairman & CEO) Sale 5,000 170.35 851,750
2015-03-05 Cox Russell J. (EVP & COO) Sale 500 175.10 87,550
2015-03-04 Wilson Karen J (SVP, Finance & PAO) Option Ex 5,159 37.15 191,631
2015-03-03 Wilson Karen J (SVP, Finance & PAO) Sale 2,598 176.27 457,949
2015-03-02 Enright Patrick G Sale 10,000 175.60 1,755,980
2015-02-10 Hooper Suzanne Sawochka (EVP & General Counsel) Sale 1,851 166.90 308,931
2015-02-10 Hooper Suzanne Sawochka (EVP & General Counsel) Option Ex 1,851 46.83 86,682
2015-02-10 Tobias Jeffrey K (EVP, R&D & CMO) Sale 5,000 166.91 834,545
2015-02-10 Tobias Jeffrey K (EVP, R&D & CMO) Option Ex 5,000 46.83 234,150
2015-02-10 Enright Patrick G Sale 10,000 167.37 1,673,650
2015-02-10 Cozadd Bruce C (Chairman & CEO) Sale 5,000 166.90 834,500
2015-01-13 Hooper Suzanne Sawochka (EVP and General Counsel) Sale 1,851 161.73 299,362
2015-01-13 Hooper Suzanne Sawochka (EVP and General Counsel) Option Ex 1,851 46.83 86,682
2015-01-13 Cozadd Bruce C (Chairman and CEO) Sale 5,000 161.73 808,650
2015-01-05 Enright Patrick G Sale 10,000 160.66 1,606,600
2014-12-26 Mulligan Seamus (Director) Sale 3,308 166.34 550,249
2014-12-24 Mulligan Seamus (Director) Sale 13,417 164.98 2,213,590
2014-12-23 Mulligan Seamus (Director) Sale 33,275 163.26 5,432,543
2014-12-12 Enright Patrick G Sale 2,343 171.51 401,843
2014-12-09 Hooper Suzanne Sawochka (EVP and General Counsel) Sale 1,852 178.79 331,119
2014-12-09 Hooper Suzanne Sawochka (EVP and General Counsel) Option Ex 1,347 46.83 63,080
 1   2 

Insider trading activities including stock purchases, stock sales, and option exercises of JAZZ listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Jazz Pharmaceuticals Inc (symbol JAZZ, CIK number 1232524) see the Securities and Exchange Commission (SEC) website.